CureCancer: Innovation in the service of medicine
The innovative tool CureCancer introduces technology to medicine, aiming to improve the quality of medical service to patients. CureCancer is a patient-centered and patient-driven tool.
CureCancer was inspired and created by Dr Dimitra Galiti, PhD candidate of the Dental School of EKPA. As Dr Galiti explains, the idea came about through the difficulties in the day-to-day care of cancer patients facing oral complications, related to their anti-cancer treatment.
Clinical and social benefits include investigating drug efficacy and toxicity as recorded by patients, and what is the best medical care. CureCancer will help increase treatment success and reduce toxicity, while maintaining patients’ quality of life within family and social and work environment.
The Scientific responsible of CureCancer, Professor Ourania Nicolatou-Galitis, explains how at the same time the financial burden/toxicity is reduced, ie the cost of cancer treatment, as well as the otherwise increased cost of supportive care.
The innovation of the startup has been recognized by the International Organization Multinational Association of Supportive Care in Cancer-MASCC, mascc.org, as well as by domestic entrepreneurship. CureCancer was hosted in the Incubator for the development of innovative start-ups-THEA of EΒEA and by "ARCHIMIDIS", Center for Innovation and Entrepreneurship, at the National and Kapodistrian University of Athens.
The pilot application of CureCancer in the Oncology community was made through the collaboration of the Hellenic Society of Oncologists of Greece-HeSMO.
On behalf of CureCancer, we warmly thank all institutions, who supported us, and especially HeSMO, for their cooperation and guidance during the study. We are grateful!
The preliminary study was presented at the European Congress of Oncology ESMO, Αbstract 1707P, ANNALS OF ONCOLOGY, 2020; 31, Suppl 4, DOI: https://doi.org/10.1016/j.annonc.2020.08.1771, με τίτλο «CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during covid-19 and reduces costs. A feasibility and satisfaction study».